BTG3 and Jeune syndrome: Patients with ATD showed a significant higher prevalence of anti-ENA, ANA, anti-Ro/SSA, anti-La/SSB, anti-dsDNA, RF, and anti-CCP antibodies in comparison with the control group (Table 1).